Skip to content

Prevention of acute coronary syndrome by aspirin in patients with breast cancer.

The reduction by acetyl salicylic acid of death rate due to acute coronary syndrome in patients with breast cancer.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/12/005235
Enrollment
1140
Registered
2014-12-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Breast Cancer

Interventions

Intervention1: Acetyl Salicylic Acid: The female breast cancer patients were asked to swallow 14mg/70Kg body weight of aspirin with water only after they have eaten a meal containing bread, fat and pr

Sponsors

Prof Asru K Sinha DSc
Lead Sponsor
Mr Soumen Maity LLB Advocate
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Breast cancer was diagnosed by mammogram followed by biopsy carried out by professional pathologists. 2. Patients were categorized by TNM (tumor size, no. of nodes & metastasis) classification at presentation. 3. Patients willing to give consent and agreed to obtain judicial affidavit from the court of law and signed informed consent form were included in the study.

Exclusion criteria

Exclusion criteria: 1. Institutionalized patients, 2. History of diabetes mellitus, 3. Systemic hypertension, 4. Severe infections, 5. Life-threatening cardiovascular diseases, 6. Cerebrovascular conditions, 7. Bundle branch block or left-ventricular hypertrophy as shown in EKG.

Design outcomes

Primary

MeasureTime frame
Number of deaths due to ACS/AMI in breast cancer patients.Timepoint: 2years

Secondary

MeasureTime frame
1. Development of hypertension every 3months for 2years. 2. Plasma glucose levels every 4 weeks for 2 years.Timepoint: 2 years

Countries

India

Contacts

Public ContactAsru Kumar Sinha

SINHA INSTITUTE OF MEDICAL SCIENCE AND TECHNOLOGY

asruksinha@yahoo.com09038975945

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026